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Summary
Objectives: Klebsiella rhinoscleromatis and Klebsiella ozaenae are associated with chronic
diseases of the upper airways: rhinoscleroma and ozena, respectively. These have become
uncommon in developed countries. We report herein one case of each disease in patients living
in Marseilles, France, and include a review of the literature.
Methods: Diagnosis was made by direct evidence of bacteria (specific cultures and autoimmu-
nohistochemistry on nasal biopsy) and using an indirect method (serology). In addition, the
literature review showed that the majority of publications were old, confirming the fact that
these diseases have been long forgotten.
Results: The specific and original methods used have allowed us to confirm the pathogenic role of
K. ozaenae in ozena and confirmed rhinoscleroma in a granulomatous lesion. In the literature, K.
rhinoscleromatis is only associated with rhinoscleroma whereas K. ozaenae is also associated with
clinical diseases other than chronic rhinitis.
Conclusions: In cases of chronic rhinitis, ozena and rhinoscleroma should be kept in mind, even in
developed countries, and systematically screened for, especially as there are specific diagnostic
tools and effective treatments available.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +33 491 38 55 17;
fax: +33 491 83 03 90.
E-mail address: didier.raoult@medecine.univ-mrs.fr (D. Raoult).
1201-9712/$32.00 # 2007 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2006.10.005Introduction
Rhinoscleroma and ozena are two clinical forms of chronic
rhinitis and can present identical clinical pictures in their
early stages.Published by Elsevier Ltd. All rights reserved.
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Figure 1 Histological examination of a nasal biopsy; typical
histiocytic granulomatous histology of the rhinoscleroma at an
advanced stage. The inflammatory infiltrates are mainly com-
posed of characteristic foamy macrophages and plasmocytes.
Figure 2 Klebsiella rhinoscleromatis is detected by immuno-
histochemical examination using the patient’s own serum at a
dilution of 1:500. Bacilli are packed as coarse immunopositive
material in foamy macrophage cytoplasm (hematoxylin counter
stain, original magnification 400).Rhinoscleroma, a chronic granulomatous disease of the
upper airways, rarely occurs nowadays in Europe, where it
was first described in 1870.1 However, it remains endemic in
tropical and subtropical areas (North and Central Africa,
Southeast Asia and Central and South America).1 Several
predisposing factors such as living under conditions of poor
hygiene and nutritional deficiencies have been described
and are apparently necessary for transmission of the dis-
ease.2 With no gender preference, it more frequently
affects young adults.3 Klebsiella rhinoscleromatis is the
etiologic agent of rhinoscleroma.1 Four overlapping clinical
stages have been described: the exudation stage, the
atrophic stage, the proliferative stage, and the cicatricial
stage.2
Ozena, meaning ‘stench’, was first described in 1876.4 It is
a rare, progressive, chronic rhinitis characterized by atrophic
changes in the nasal mucosa with resorption of the underlying
bone, formation of a thick and greenish crust, and a distinct
fetid odor.5 The diagnosis is clinical: enlargement of the nasal
passages and a foul-smelling mucopurulent discharge that
tends to dry into crusts.5 This disease, endemic in poor
countries, is rarely isolated in developed countries because
of better hygiene conditions.6 The pathogenesis of ozena is
very poorly understood, although a variety of theories have
been suggested.4—7 According to the microbial theory, the
causative organism is considered to be Klebsiella ozaenae,
from which the name ozena comes. However, its role in the
disease has not been firmly established.1,5 Yet, the bacterium
is the most regularly found in ozena.
Patients and methods
Case reports
Case 1. A 38-year-old woman from Senegal, who had been
living in France since 2001, presented at the hospital with a
past history of surgical cure of rhinoscleroma in 2001, asso-
ciated with one month of local and general ofloxacin treat-
ment. Beginning in June 2004, she suffered from nasal
obstruction and chronic rhinorrhea in spite of the previous
treatment. A biopsy of the nasal mucosa was performed in
October 2004. A recurrence of the rhinoscleroma was noted
by means of histology (Figure 1). Klebsiella rhinoscleromatis
was isolated by bacteriologic culture of the nasal discharge.
The bacterium was susceptible to amoxicillin—clavulanic
acid, to rifampin and cotrimoxazole and resistant to amox-
icillin and ticarcillin. Serology and immunochemistry were
done (Figures 2—4). Biological examinations showed no
abnormalities and the ratio CD4/CD8 = 1. A magnetic reso-
nance imaging (MRI) scan was performed and showed bilat-
eral and asymmetrical nasal masses with mild high signal
intensity on T1- and T2-weighted images. The patient was
treated with rifampin 900 mg per day and cotrimoxazole (six
tablets per day of sulfamethoxazole 800 mg/trimethoprim
160 mg) for six months and her clinical course was followed at
regular consultations. Nasal discharge cultures from the
patient’s family were negative.
Case 2. A 72-year-old Caucasian woman presented with a
crusting rhinitis and foul greenish discharge mainly from the
right nostril. She complained of bad nose smells, or cacos-
mia, and repetitive bronchitis. A previous culture of thenasal discharge had been performed and had grown Sta-
phylococcus aureus; treatment with pristinamycin and local
fusidic acid was undertaken without success. She was
referred to our microbiological department and further
cultures from nasal discharge and sputum were performed;
these grew Klebsiella ozaenae, resistant to amoxicillin,
amoxicillin—clavulanic acid and ticarcillin, and susceptible
to cotrimoxazole. Nasal endoscopy showed an inflamed
right mucosa with a greenish discharge. A nasal biopsy
performed made no contribution to the diagnosis. Biologi-
cal examinations showed no abnormalities except for the
CD4/CD8 ratio, which was altered showing increased CD4
lymphocytes. With cotrimoxazole (six tablets per day of
sulfamethoxazole 800 mg/trimethoprim 160 mg) treat-
ment, improvement was noted on endoscopy. After three
months of treatment, cotrimoxazole had to be ceased due
to a mild skin reaction.
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Bacteriology
The nasal discharge specimens were inoculated onto trypti-
case soy agar (bioMe´rieux, Marcy l’Etoile, France) and man-
nitol salt agar (bioMe´rieux) and incubated at 37 8C in a 5% CO2
atmosphere. Identification was made using API-20E system
(bioMe´rieux) and susceptibility tests were performed with
the VITEK automated system (bioMe´rieux). An rpoB gene
sequence analysis was performed in the second case to
confirm identification of the strain isolated.
Immunohistochemistry
After a classical histological study of a nasal biopsy, an auto-
immunohistochemistry method (described elsewhere8) was
used on the nasal biopsies as an original diagnosis technique.
Immunochemistry was considered as positive when we could
see microorganisms. These microorganisms were either
extracellularly or intracellularly (in macrophages or polymor-
phonuclear leukocytes) located. Immunochemistry was con-
sidered as negative when no microorganisms were seen.
Serology
In the two cases, serology was performed on sera taken in the
acute phase of the disease and repeated during the clinical
follow-up. Two methods were used: indirect immunofluores-
cence staining as the screening method and Western blot
staining done in parallel as the confirmation method. Sera
from 20 blood donors were used as negative control.
Klebsiella spp strains antigen preparation
Klebsiella pneumoniae subsp ozaenae and Klebsiella pneu-
moniae subsp rhinoscleromatis strains were obtained from
the nasal discharge of the patients reported. The Klebsiella
pneumoniae subsp pneumoniae strain was obtained from a
patient with a urinary tract infection. All the Klebsiella spp
strains were inoculated in trypticase soy agar (bioMe´rieux) for
antigen production at 37 8C. A concentration of 108 bacteria
was resuspended in 1 ml of phosphate-buffered saline (PBS).
Immunofluorescence staining
The antigen preparations were applied with a drawing pen to
the center of an 18-well microscope slide (Dynatech Labora-
tories Ltd, Billingshurst, UK), air dried, and fixed in ethanol.
Sera were serially diluted (two-fold dilution initially ranging
1:25 to 1:1600) in PBS with 3% non-fat dry milk. The overlaid
antigenswere incubated in amoist chamber for30 minat 37 8C
and washed twice in PBS for 10 min and once in distilled water
for 5 min. After air-drying the slides were overlaid with fluor-
escein isothiocyanate-conjugated goat anti-human IgG (Fluo-
line G; bioMe´rieux, Marcy l’Etoile, France), anti-human IgM
(Fluoline M; bioMe´rieux), or anti-human IgA (Fluoline A; bio-
Me´rieux) diluted at 1:300. Incubation, washes and drying were
performed again as described above. The slidesweremounted
in buffered glycerol (Fluoprep; bioMe´rieux) and read with a
Zeiss fluorescent microscope at 400 magnification.
Western immunoblotting staining
Proteins of the antigen preparations were determined by UV
spectrophotometry and adjusted to 1 mg/ml. Proteins of bac-
teria were extracted and heated as described elsewhere.9 Atotal of 10 mg of total protein was loaded per lane. Ten
microliters of the preparation was electrophoresed at 100 V
for 90 minutes through 10% acrylamide separating gels with
30% acrylamide stacking gels with a Mini-Protean III cell appa-
ratus (Bio-Rad, Hercules, CA, USA). A mixture of pre-stained
molecularmass standards (Kaleidoscope; Bio-Rad)was used to
estimate the molecular masses of the separated antigens.
Resolved antigens were then transferred to a 0.45-mm pore-
size nitrocellulosemembrane (Bio-Rad) for 80 minutes at 15 8C
and 100 V. The blots were blocked overnight at 4 8C with 5%
non-fat milk powder in PBS buffer and washed with distilled
water. Sera (diluted 1:200 in PBS—0.5% non-fat milk powder)
were applied to the blots for 1 h at room temperature. After
three 10-min washes in PBS—0.5% non-fat milk powder, the
blots were incubated for 1 h with peroxidase-conjugated goat
anti-human Ig (H+L)-HRP (Southern Biotechnology Associates
Inc., Birmingham,AL,USA) diluted1:1000 inPBS—0.5%non-fat
milk powder. The blots were washed three times in PBS and
bound conjugate was revealed by incubation with a solution
consisting of 0.015% 4-chloro-1-naphthol (Sigma, St. Louis,
MO, USA) and 0.015% hydrogen peroxide in PBS—16.7% metha-
nol for 5 min. Western blot analysis was performed before and
after cross-adsorption.
Data review
We conducted a literature search using MEDLINE, without
time limits, cross-referencing the following terms: (1) Kleb-
siella pneumoniae ozaenae or ozena, (2) Klebsiella pneumo-
niae rhinoscleromatis or rhinoscleroma, (3) atrophic rhinitis.
Only articles written in English and French and dealing with
human cases were reviewed. The review of the literature
yielded 237 articles for category 1, 233 articles for category
2, 218 articles for category 3, 229 articles for categories
1 + 2, 218 articles for categories 1 + 3, eight articles for
categories 2 + 3, and 207 articles for categories 1 + 2 + 3.
Only 20% of articles relating to category 1 and category 2
were found to have been written in the last ten years. After a
rapid appraisal of the available abstracts on MEDLINE, we
selected case reports and available reviews for further study:
eight articles concerning rhinoscleroma, six concerning K.
ozaenae, four concerning ozena and atrophic rhinitis, and
four concerning rhinoscleroma and ozena.
Results
In our first case, after 24 h of incubation on trypticase soy
agar, aerobic culture of the nasal discharge revealed abun-
dant growth ofmucoid colonies. Gram stains revealed Gram-
negative rods. Identification based on biochemical charac-
teristics was performed with API-20E system (bioMe´rieux)
and showed Klebsiella rhinoscleromatis. Histological exam-
ination of a nasal biopsy revealed an infiltrate composed of
Mikulicz’s cells and plasmocytes containing Russell bodies
(Figure 1). Special stains for bacteria were employed but
failed to show Gram-negative bacteria. An autoimmunohis-
tochemistry technique realized on a nasal biopsy was posi-
tive (Figure 2) and showed K. rhinoscleromatis using the
patient’s own serum at a dilution of 1:500. Bacilli are found
packed as coarse immunopositive material in foamy macro-
phage cytoplasm. Serology was performed with immuno-
fluorescence staining and was positive with high titers
for K. rhinoscleromatis: IgA = 100, IgM = 0 and IgG = 800
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Figure 3 Western immunoblotting for the patient reported in our first case showing an antibody response directed against outer
membrane proteins of K. rhinoscleromatis only. Lane 1 = reference strain of Klebsiella rhinoscleromatis; lane 2 = K. rhinoscleromatis:
strain of our patient; lane 3 = a strain of Klebsiella ozaenae (strain of our second patient); lane 4 = a strain of Klebsiella pneumoniae.
MW = molecular weight; kDa = kilodalton. (a) Cross adsorption performedwith K. rhinoscleromatis: strain of reference and strain of our
first patient. (b) Cross adsorption performed with K. ozaenae (strain of our second patient). (c) Cross adsorption performed with K.
pneumoniae.
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Figure 4 Western immunoblotting for the patient reported in
our second case showing an antibody response directed against
outer membrane proteins of Klebsiella ozaenae only. Lane
1 = reference strain of Klebsiella rhinoscleromatis; lane 2 = strain
of K. rhinoscleromatis of our first patient; lane 3 = K. ozaenae
strain of our patient; lane 4 = a strain of Klebsiella pneumoniae.
MW = molecular weight; kDa = kilodalton.(Figure 3). The negative controls (blood donors) were nega-
tive. Serology was performed against K. ozaenae and K.
pneumoniae, and was negative. The diagnosis of rhinoscler-
oma was confirmed with a Western blot assay and cross-
adsorption with antigens of K. rhinoscleromatis, K. ozaenae
and K. pneumoniae (Figure 3a—c). Serology was used to
follow the clinical course of the disease and remained
unchanged with the same titers even after the end of
treatment. One month following the start of treatment,
cultures of nasal swabs were sterile and remained sterile
within the 6-month follow-up period.In our second case, the
use of a trypticase soy agar allowed us to isolate Klebsiella
ozaenae. This bacterium had not previously been isolated in
this patient in spite of a great number of nasal discharge
samples. The identification of the bacterium was based on
phenotypic characteristics, performed with the API-20E
system (bioMe´rieux). In particular, the bacterium differs
from K. rhinoscleromatis for o-nitrophenyl-beta-D-galacto-
pyranoside (ONPG), melibiose, saccharose and arabinose.
The nasal biopsy showed only inflammatory and fibrosis
damage of the nasal mucosa and failed to show atrophic
rhinitis with metaplastic changes in the mucus glands. This
biopsy was undoubtedly made on a part of the nasal mucosa
that was free of lesions. An autoimmunohistochemistry
technique performed on a nasal biopsy was negative for
the same reasons. The rpoB gene sequence analysis of the
strain failed to identify Klebsiella pneumoniae subsp ozae-
nae and identified Klebsiella pneumoniae without distinc-
tion of subspecies. Serology with immunofluorescence
staining was performed and was positive with high titers
for Klebsiella ozaenae: IgA = 400, IgM = 0 and IgG = 800. All
the negative controls (blood donors) tested for K. rhino-
scleromatis, K. ozaenae and K. pneumoniae serology were
negative. The diagnosis of ozena was confirmed with a
Western blot assay (Figure 4). After two months of treat-
ment, culture of nasal swabs was sterile. However, one
month later the patient presented with a skin reaction to
the cotrimoxazole and, given the sterility of nasal speci-
mens, the treatment was stopped. Fifteen days later she
relapsed. After relapse and during follow-up, serology
remained unchanged, at the same titers.
In our laboratory, we made a retrospective study for the
period from 1 January 2001 to 31 December 2004, of the
number of isolates of these bacteria. K. rhinoscleromatis
was isolated once (in our reported patient). In the same
period, K. ozaenae was isolated 13 times in eight patients:
three times in urine, one time in sputum, two times in blood,
two times in skin samples, twice in a digestive abscess, and
three times in nasal swabs (in the case reported herein). By
comparison, during the same period, K. pneumoniae was
isolated 67 times.
In the literature, K. rhinoscleromatis was found in several
case reports of rhinoscleroma.1,10—13 The majority of papers
were written more than ten years ago. The disease usually
involved the nasopharynx,2 but extension to other sites was
described.2,3,12 To the best of our knowledge, only two cases
of bacteremia due to K. rhinoscleromatis have been
reported.10,14 K. ozaenae was described associated with
ozena in papers written more than 20 years ago1,6 or more
recently.15 Unlike K. rhinoscleromatis, K. ozaenae was
described in other clinical diseases than chronic rhinitis such
as meningitis,16 cerebral abscess,17 bacteremia,10,16,18—21and pyogenic hepatic abscess with septic pulmonary emboli
associated with bacteremia.20 Most clinical isolates of K.
ozaenae originated from patients without any evidence of
ozena.5 Accordingly, some authors consider this organism to
be an opportunistic colonizer.5 Moreover, in many cases of
ozena, K. ozaenae is only one among multiple bacteria
isolated from patients.5 It has been found in patients with
various underlying diseases such as alcoholism, diabetes
mellitus, neoplasia, and immunosuppression.22
Discussion
In the first case reported, the diagnosis of rhinoscleroma is
certain. Indeed, a positive culture of K. rhinoscleromatis is
diagnostic of rhinoscleroma because it is not found in normal
nasal secretions.3 In addition, symptoms appeared in a patient
originating from an endemic area, who had a previous history
of rhinoscleroma. We noted that no relative of our case has
been contaminated. Our patient was seen in the third stage of
the disease in which histological findings are typical. The
presence of an infiltrate composed of plasma cells, lympho-
cytes, Russell bodies, Mikulicz’s cells, and Gram-negative
bacilli in the sub-epithelium is characteristicof rhinoscleroma,
but not pathognomonic.3 The autoimmunohistochemistry
method, which indicates an infectious process, could help in
differential diagnoses for other granulomatous diseases of the
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same as already described and could help to differentiate
masses of rhinoscleroma from neoplasm.18
In the second case, the patient presented the character-
istic signs of disease: she had enlargement of the nasal
passages and a foul-smelling mucopurulent discharge that
tended to dry into crusts. In ozena, the diagnosis is clinical.5
Atrophic rhinitis with metaplastic changes of the mucus
glands are characteristically found in patients with ozena.5
For our patient a nasal biopsy was negative, a result undoubt-
edly due to the fact that it was taken from an area without
any lesions. No further biopsy was performed to confirm this
result. Because histology was not contributory, autoimmu-
nohistochemistry could not help in the diagnosis. In this case,
serology was very helpful to confirm that K. ozaenae had a
pathogenic role.
K. rhinoscleromatis and K. ozaenae grew better on trypti-
case soy agar than on MacConkey agar. According to pheno-
typic characterization, K. rhinoscleromatis and K. ozaenae
were differentiated from K. pneumoniae on the basis of
reactions to lysine, citrate, urea and Voges—Proskauer, which
are positive in K. pneumoniae. K. rhinoscleromatis (patient
1) was identified on the basis of being ONPG negative,
melibiose negative and saccharose positive. K. ozaenae
(patient 2) was identified by a positive ONPG reaction,
positive melibiose and negative saccharose. Taxonomically,
the two species K. rhinoscleromatis and K. ozaenae are
regarded as subspecies of K. pneumoniae based on DNA—
DNA hybridization data.23 The sequences of K. pneumoniae
subsp pneumoniae, subsp rhinoscleromatis, subsp ozaenae
and Klebsiella granulomatis isolates exhibited a 98.2—99.7%
16S r DNA sequence similarity and 99.4—100% rpoB sequence
similarity.23 K. pneumoniae subsp ozaenae and K. granulo-
matis are also indistinguishable on the basis of their rpoB
sequence.23 Thus, it is impossible to differentiate the sub-
species of K. pneumoniae by methods of molecular biology as
with the rpoB gene sequence analysis.
To the best of our knowledge, the incidence of ozena and
rhinoscleroma is little known in developed countries.7 It is
doubtless more common in poor countries. Ozena has been
reported to account for 0.3—7.8% of ear, nose and throat
diseases in endemic areas.4,7 In our laboratory, the causative
bacteria are very rarely isolated. Thus, nowadays, these two
diseases have become rare in developed countries and are no
longer ‘remembered’ by physicians. A low index of suspicion
in non-endemic areas could explain the delay in its diagnosis
and in its management.12,13 Sporadic cases of rhinoscleroma
may have increased in recent years, due to emerging immi-
gration from endemic areas.3 These two forms of chronic
rhinitis can have social repercussions, notably in ozena where
the cacosmia can be a real social handicap. Rarely, the
diagnosis delay may have severe consequences for outcome,
as has occurred in rhinoscleroma.12
For the time being, these bacteria are not included in
routine analyses. For example, as a routine in our laboratory
nasal swabs are cultured only on mannitol salt agar (bioMe´r-
ieux) for isolation of Staphylococcus aureus. Cultures on
trypticase soy agar (bioMe´rieux) or other agar would only
bemade if ozena or rhinoscleroma, or other specific diseases,
are suspected by the physician. In our second case, many
nasal swabs were carried out without isolation of K. ozaenae
and it was only because the physician was aware of ozenathat we cultured on other agar plates (MacConkey, trypticase
soy, chocolate (bioMe´rieux)).
In these two ‘forgotten’ infectious diseases, diagnosis could
be aided with the use of the newmethods of diagnosis that we
have used in our cases. Serology methods have already been
described in cases of rhinoscleroma.3 High titers of specific
antibody were found in patients with active disease. These
tests are diagnostic but are only of value when positive.3 The
immunofluorescence staining assay used in our cases showed a
high titer of IgA as is seen in mucosa infections. We followed
the clinical course of our patients under treatment with this
method. Conversion to a negative reaction was described in
parallel to the clinical regression of the lesion in rhinoscler-
oma.3 However we did not observe any evolution in our
patients’ serology, neither in the case of the cured patient
nor in the case of the one who relapsed. Serology seems to be
very interesting for confirmation of rhinoscleroma, and even
more so where ozena is concerned, because it reveals that the
bacterium occurs in a pathogenic situation and is not only a
colonizer.Moreaccuratedetectionand identificationofmicro-
organisms can be obtained thanks to the application of the
immunoperoxidase method to paraffin sections. We used a
recent immunoperoxidase technique with the patient’s own
serum, called autoimmunochemistry.8 The patient’s serum is
considered as the source of primary antibodies.24 In our first
case, this method was positive and confirmed the presence of
bacteria. In the second case, it was negative but the nasal
biopsyhadprobably only beenperformedona healthy location
and revealed only a fibrosis tissue without any pathologic
mucosa. These two methods are interesting in the positive
diagnosis of these two forms of chronic rhinitis and can con-
tribute to a better knowledge ofwhat the prevalences of these
diseases are.
An adequate and prolonged antimicrobial treatment must
be established in these two types of chronic rhinitis. K.
rhinoscleromatis is widely sensitive to the majority of anti-
biotics that are active on Gram-negative bacteria except for
penicillin, ampicillin and sulfonamide.3 Perkins et al.,
showed that ciprofloxacin and rifampin are the most active
drugs.25 The association of trimethoprim—sulfamethoxazole
is the best compromise in terms of efficacy/cost.2 In the case
of our first patient, rifampin associated with cotrimoxazole
was used with good results. In ozena, Goldstein et al. also
studied antimicrobial susceptibility of K. ozaenae and
reported 26% of strains susceptible to ampicillin.5 Berger
et al., in a prior study, reported their bacterium isolates
to be susceptible to ampicillin.10 In the case of our second
patient, the isolate was resistant to ampicillin. Relapses are
common in these forms of chronic rhinitis, so it is necessary to
follow the patient closely.2,3 Obtaining a negative biopsy
culture before stopping antibiotic therapy is recommended.3
Serology could avoid the need to take a biopsy if it shows a
conversion to a negative reaction,3 but in the case of our first
patient, she seemed to be cured and serology persisted
unchanged.
The aimof this reviewwas to give a progress report on two
forms of forgotten chronic rhinitis: ozena and rhinoscler-
oma. These two diseases have become rare in developed
countries thanks to better hygiene. For the timebeing, these
two pathologies may be missed by routine microbiological
examinations (nasal swabs). It is thus necessary to keep
these pathologies in mind, in order to perform targeted
Chronic nasal infection caused by K. rhinoscleromatis or K. ozaenae 429research. For diagnosis, we used two effective methods
using the patient as his/her own witness: serology and
autoimmunochemistry. Therefore patient follow-up is facili-
tated, and a relapse or any ineffectiveness of treatment can
be highlighted.
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